real world evidence for myeloma patients on (ird) ixaxomib/lenalidomide/dex | ash 2021
Published 2 years ago • 102 plays • Length 7:59Download video MP4
Download video MP3
Similar videos
-
55:54
accelerating myeloma research with real world data at the healthtree foundation for multiple myeloma
-
1:00
multiple myeloma life expectancy
-
2:02
assessing lenalidomide with patients progressing on jak inhibitors | james berenson, md | ash 2023
-
5:20
advancements in myeloma treatment: real world outcomes and quality of life | doris hansen, md
-
3:10
ash 2021 highlights | saad usmani, md
-
0:44
how advances in multiple myeloma research are extending lives
-
2:02
real-world patient profile and dosing of teclistamab in myeloma | carlyn rose tan, md | ash 2023
-
0:53
what is multiple myeloma?
-
55:30
how personalized is myeloma treatment and how is changing? introducing the individual risk model
-
57:49
know your myeloma therapy: what's available for maintenance therapy?
-
4:59
real-world schedule de-escalation of teclistamab in patients with rrmm | carlyn tan, md | eha 2024
-
59:49
using revlimid as a successful treatment for myeloma patients with kidney involvement
-
1:00
should we change our clinical practice for multiple myeloma based on mrd?
-
0:31
tom brokaw discusses being diagnosed with multiple myeloma #shorts
-
2:51
multiple myeloma and increased covid-19 risk using real-world data | emily liu | ash 2021
-
1:09
what are clinical trials in myeloma? #myeloma
-
59:57
what's available for induction therapy in multiple myeloma
-
2:45
real world data on ide-cel efficacy and side effects profile | rafat abonour, md | ims 2024
-
59:13
furthering myeloma research in search for a cure